Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01135797 · ClinicalTrials.gov registry record
Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials
A clinical trial, sponsored by Sanofi.
- Completed
- Registry status
- 164
- Enrollment target
NCT01135797: Completed study, sponsored by Sanofi.
NCT01135797 is a clinical trial that has completed, run by Sanofi. The registered enrollment target is 164 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01135797 has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- 164 participants
- Enrollment target
Study Summary
The objective of this study is to collect retrospectively long term safety data in patients who have participated in the previous phase I-II trials conducted with the compound.
Primary Outcome
Including all causes of deaths
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2010-06 |
| Est. Completion | 2010-12 |
What the finished NCT01135797 record still lists
NCT01135797 is an observational study that tracks outcomes without assigning an intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01135797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01135797 about?
NCT01135797 is a clinical study titled "Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials". The objective of this study is to collect retrospectively long term safety data in patients who have participated in the previous phase I-II trials conducted with the compound.
What is the current status of trial NCT01135797?
This trial is currently completed. The enrollment target is 164 participants. The study started on 2010-06. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01135797?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia